MedPath

lidocaine

Lidocaine Ointment, 5% for topical use DO NOT USE IN THE EYES Rx Only

Approved
Approval ID

1361b4e3-bcbb-4dec-8aaa-b06bb2c3c0a4

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 22, 2023

Manufacturers
FDA

FORREAL PHARMACEUTICALS LLC

DUNS: 118029197

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

lidocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code81877-519
Application NumberANDA206498
Product Classification
M
Marketing Category
C73584
G
Generic Name
lidocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateAugust 22, 2023
FDA Product Classification

INGREDIENTS (3)

POLYETHYLENE GLYCOL 1450Inactive
Code: OJ4Z5Z32L4
Classification: IACT
LIDOCAINEActive
Quantity: 50 mg in 1 g
Code: 98PI200987
Classification: ACTIB
POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQ
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

lidocaine - FDA Drug Approval Details